Pancreatic cancer is at least four separate diseases each with a different cause and needing a different treatment, scientists have discovered.
The researchers say the knowledge will lead to new drugs targeting the ‘Achilles’ heel’ of each patient’s cancer and that they have already seen some “exceptional” results.
The researchers believe this will allow for new drugs which target the individual diseases, resulting in more successful drugs for pancreatic cancer.
Continue reading “Pancreatic cancer formed of at least four separate diseases, study finds”
Study finds chemo brain exercises help with symptoms
People experiencing problems with their memory and concentration following chemotherapy treatment can help overcome symptoms using simple online brain training exercises.
Cancer survivors often comment on both memory and concentration problems after having had chemotherapy treatment, this is often refered to as ‘chemo brain’.
A group of researchers found that 40 minutes a day, four times a week for 15 weeks of online brain training resulted in a significant improvement of these cognitive symptoms.
Continue reading “Online puzzle exercises used to tackle chemo brain”
Researchers have begun using a new diagnostic tool to detect prostate cancer in urine samples.
This may eliminate the need for the current diagnostic tools which use painful probes or the prostate-specific antigen exam, according to Healthline. They are hoping that in a decade this sort of diagnostic test will be the standard, and will help with diagnosing cancer as soon as possible.
Continue reading “Researchers working on ‘less painful’ prostate cancer test”
Blood tests are the latest tool in cancer treatment. By taking blood, scientists can detect changes in DNA that can help to assess the presence of cancer cells in the body.
A blood test with the ability to detect five different forms of cancer by looking for abnormal DNA signatures may be close to becoming a reality.
Researchers were able to identify womb, lung, stomach, colon and breast tumours from normal tissue by the DNA signature around the gene ZNF 154.
There is hope that the potential of this diagnostic technique will lead to earlier diagnosis in people resulting in a higher survival rate.
The research has been carried out by the National Human Genome Research Institutes in the US and published by the Journal of Molecular Diagnostics.
An exciting development in chemotherapy drug delivery means that targeting tumours will soon be easier.
Scientists have found a way to reduce the necessary dose of an existing chemo drug by making sure the full amount of the drug reaches the tumour rather than being partially destroyed as it travels through the body. “That means we can use 50 times less of the drug and still get the same results – more effective treatment with fewer and milder side effects.”
Continue reading “Anti-Cancer Drug Made More Effective To Reduce Side Effects”
A genomics company is developing technology that could spot cancer signs in healthy people from as a little as a few drops of blood.
Although others have succeeded in creating blood tests to detect tumour relapses or cancer progression, spotting cancer signs in healthy bodies is the holy grail.
Continue reading “Blood test could detect symptomless early stage cancer”
It’s early days, but researchers are making great strides in the search for alternatives to chemo.
The latest study, led by scientists from the MD Anderson Cancer Center, has found that some people with the most common kind of leukaemia – chronic lymphocytic leukaemia – did better with an anticancer drug called ibrutinib than those who were given chemo.
Continue reading “The kind of cancer that may not need chemo”